STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027

A retinal implant approved in Europe can partially restore vision for patients with age-related macular degeneration, potentially improving reading and road sign visibility. The device, developed by Science Corporation, may launch in the U.S. in 2027. CEO Max Hodak described it as a 'cochlear implant for vision.'